Zobrazeno 1 - 10
of 76
pro vyhledávání: '"MESH: Leukemia, Myeloid"'
Autor:
Giebel, Sebastian, Labopin, Myriam, Sobczyk-Kruszelnicka, Malgorzata, Stelljes, Matthias, Byrne, Jenny, Fegueux, Nathalie, Beelen, Dietrich, Rovira, Montserrat, Spyridonidis, Alexandros, Blaise, Didier, Bornhäuser, Martin, Karadogan, Ihsan, Savani, Bipin, Nagler, Arnon, Mohty, Mohamad, Martin, Sonja, Chevallier, Patrice, Neubauer, Andreas, Damaj, Gandhi, Koc, Yener, Ganser, Arnold, Collin, Matthew, Yakoub-Agha, Ibrahim, Ozdogu, Hakan, Araujo, Mercedes Colorado, Itäla-Remes, Maija, Orchard, Kim, Isaksson, Cecilia, Bethge, Wolfgang, Martin, Hans, Aljurf, Mahmoud, Faber, Edgar, Caballero, Dolores, Zák, Pavel, Leleu, Xavier, Bay, Jacques-Olivier, Rohrlich, Pierre-Simon, Kröger, Nicolaus, Huynh, Anne, Schäfer-Eckart, Kerstin, Milpied, Noel, Lenhoff, Stig, Ho, Aloysius, López, Jose Luis Bello, Mordini, Nicola, Lioure, Bruno, Halaburda, Kazimierz, Olivieri, Attilio, Gedde-Dahl, Tobias, Protheroe, Rachel, Tischer, Johanna, Klammer, Matthias, Clausen, Johannes, Potter, Victoria, Ladetto, Marco, Tilly, Herve, Deconinck, Eric, Brecht, Arne, Müller, Lutz Peter, Heinicke, Thomas, Carrete, Juan Pio Torres, Bazarbachi, Ali, Reményi, Péter, Rubio, Marie Thérèse, Fanin, Renato, Pérez-Simón, Jose Antonio, Niels, Murawski, Diez-Martin, J., Arat, Mutlu, Hermine, Olivier, Socié, Gerard, Cornelissen, Jan, Santarone, Stella, Guyotat, Denis, Bulabois, Claude Eric, Bernasconi, Paolo, Johansson, Jan-Erik, Vrhovac, Radovan, Greinix, Hildegard, Lorenzo, José Luis López, Apte, Shashikant, Craddock, Charles, Kobbe, Guido, Zahrani, Mohsen Al, Dreger, Peter, Lange, Andrzej, Tbakhi, Abdelghani, Meijer, Ellen, Llamas, Carlos Vallejo, Santasusana, Josep Maria Ribera, Corradini, Paolo, Benedetti, Fabio, Rambaldi, Alessandro, Gandemer, Virginie, Malfuson, Jean-Valère, Kaare, Ain, Risitano, Antonio, Petrini, Mario, Selleri, Carmine, Wu, Depei
Publikováno v:
Bone Marrow Transplantation, 56(2), 481-491. Nature Publishing Group
Giebel, S, Labopin, M, Sobczyk-Kruszelnicka, M, Stelljes, M, Byrne, J L, Fegueux, N, Beelen, D W, Rovira, M, Spyridonidis, A, Blaise, D, Bornhäuser, M, Karadogan, I, Savani, B N, Nagler, A, Mohty, M & Principal investigators of the contributing institutions 2021, ' Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT ', Bone Marrow Transplantation, vol. 56, no. 2, pp. 481-491 . https://doi.org/10.1038/s41409-020-01050-7
Bone Marrow Transplantation
Bone Marrow Transplantation, 2021, 56 (2), pp.481-491. ⟨10.1038/s41409-020-01050-7⟩
Giebel, S, Labopin, M, Sobczyk-Kruszelnicka, M, Stelljes, M, Byrne, J L, Fegueux, N, Beelen, D W, Rovira, M, Spyridonidis, A, Blaise, D, Bornhäuser, M, Karadogan, I, Savani, B N, Nagler, A, Mohty, M & Principal investigators of the contributing institutions 2021, ' Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT ', Bone Marrow Transplantation, vol. 56, no. 2, pp. 481-491 . https://doi.org/10.1038/s41409-020-01050-7
Bone Marrow Transplantation
Bone Marrow Transplantation, 2021, 56 (2), pp.481-491. ⟨10.1038/s41409-020-01050-7⟩
International audience; The optimal conditioning for patients with acute myeloid leukemia in first complete remission treated with allogeneic hematopoietic cell transplantation (allo-HCT) has not been defined so far. In this retrospective study, we c
Autor:
Christian Recher, Eric Jourdan, Anne Banos, Claire Jouzier, Franciane Paul, Bruno Lioure, Romain Guieze, Norbert Ifrah, Pierre-Yves Dumas, Caroline Bonmati, Arnaud Pigneux, Jean-François Hamel, Mathilde Hunault, Jean-Yves Cahn, Jean-Christophe Ianotto, Mario Ojeda-Uribe, Marc Bernard, Norbert Vey, Marie-Christine Béné, Hacene Zerazhi, Jacques Delaunay
Publikováno v:
European Journal of Haematology
European Journal of Haematology, 2021, 106 (6), pp.859-867. ⟨10.1111/ejh.13624⟩
European Journal of Haematology, 2021, 106 (6), pp.859-867. ⟨10.1111/ejh.13624⟩
International audience; Objectives: The impact of conventional treatment for acute myeloid leukemia (AML) on the nutritional, cognitive, and functional status of elderly patients is seldom studied. This assessment was performed in the context of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c96092e9a79c198e837438382537c88
https://hal.science/hal-03670311
https://hal.science/hal-03670311
Autor:
Alexandra Neaga, Cristina Bagacean, Adrian Tempescul, Laura Jimbu, Oana Mesaros, Cristina Blag, Ciprian Tomuleasa, Corina Bocsan, Mihaela Gaman, Mihnea Zdrenghea
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, 2021, 11, pp.582915. ⟨10.3389/fimmu.2020.582915⟩
Frontiers in Immunology, Vol 11 (2021)
Frontiers in Immunology, 2021, 11, pp.582915. ⟨10.3389/fimmu.2020.582915⟩
Frontiers in Immunology, Vol 11 (2021)
International audience; Acute myeloid leukemia (AML) is an aggressive myeloid malignancy with poor outcomes despite very intensive therapeutic approaches. For the majority of patients which are unfit and treated less intensively, the prognosis is eve
Autor:
Manfred Jung, Karin Schmidtkunz, Elizabeth R Morales, Stefan Günther, Wolfgang Sippl, Martin Hügle, Frank Erdmann, Patrik Zeyen, Ehab Ghazy, Dina Robaa, Christophe Romier, Matthias Schmidt, Daniel Herp
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 2020, 200, pp.112338. ⟨10.1016/j.ejmech.2020.112338⟩
European Journal of Medicinal Chemistry, Elsevier, 2020, 200, pp.112338. ⟨10.1016/j.ejmech.2020.112338⟩
European Journal of Medicinal Chemistry, 2020, 200, pp.112338. ⟨10.1016/j.ejmech.2020.112338⟩
European Journal of Medicinal Chemistry, Elsevier, 2020, 200, pp.112338. ⟨10.1016/j.ejmech.2020.112338⟩
International audience; Histone modifying proteins, specifically histone deacetylases (HDACs) and bromodomains, have emerged as novel promising targets for anticancer therapy. In the current work, based on available crystal structures and docking stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::738621ff6d5b1624d9660f91e10c4ab7
https://hal.science/hal-02999300/document
https://hal.science/hal-02999300/document
Autor:
Samia Menif, Amel Lakhal, Yosra Ben Youssef, Raihane Ben Lakhal, Manel Bedoui, Z. Manai, Mohamed Adnène Laatiri, Tarek Ben Othmen, Hela Ghedira, Neila Ben Romdhane, Abderrahmane Khélif, Hatem Bellaaj, F. Msadek, Balkis Meddeb, Moez Elloumi
Publikováno v:
Annals of Hematology
Annals of Hematology, Springer Verlag, 2018, 97 (4), pp.597--604. ⟨10.1007/s00277-017-3224-2⟩
Annals of Hematology, Springer Verlag, 2018, 97 (4), pp.597--604. ⟨10.1007/s00277-017-3224-2⟩
International audience; Data are limited in developing countries regarding the clinicopathologic features and response to therapy of chronic myeloid leukemia (CML) in the era of imatinib (IM). The objective of this study is to report on the clinicoep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66925fcc39af00c0fb63c3b0c040da14
https://hal.archives-ouvertes.fr/hal-01876259
https://hal.archives-ouvertes.fr/hal-01876259
Autor:
Bruno Lacarelle, Régis Costello, Le Thi Thu Hau, Mélanie Donnette, Caroline Solas, Madeleine Giocanti, Raphaelle Fanciullino, Geoffroy Venton, L'Houcine Ouafik, Laure Farnault, Joseph Ciccolini, Yael Berda-Haddad
Publikováno v:
Journal of Chromatography B Biomedical Sciences and Applications
Journal of Chromatography B Biomedical Sciences and Applications, Elsevier, 2019, 1126-1127, pp.121770. ⟨10.1016/j.jchromb.2019.121770⟩
Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences
Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, Elsevier, 2019, 1126-1127, pp.121770. ⟨10.1016/j.jchromb.2019.121770⟩
Journal of Chromatography B Biomedical Sciences and Applications, 2019, 1126-1127, pp.121770. ⟨10.1016/j.jchromb.2019.121770⟩
Journal of Chromatography B Biomedical Sciences and Applications, Elsevier, 2019, 1126-1127, pp.121770. ⟨10.1016/j.jchromb.2019.121770⟩
Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences
Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, Elsevier, 2019, 1126-1127, pp.121770. ⟨10.1016/j.jchromb.2019.121770⟩
Journal of Chromatography B Biomedical Sciences and Applications, 2019, 1126-1127, pp.121770. ⟨10.1016/j.jchromb.2019.121770⟩
International audience; Purine analogs like aracytine (AraC) are a mainstay for treating acute myeloid leukemia (AML). There are marked differences in drug dosing and scheduling depending on the protocols when treating AML patients with AraC. Large i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::197713233e52e8e17267586de653535b
https://hal-amu.archives-ouvertes.fr/hal-02483206
https://hal-amu.archives-ouvertes.fr/hal-02483206
Autor:
Fourmont, Aude-Marie
Publikováno v:
Médecine humaine et pathologie. 2019
Introduction: although the majority of adult acute myeloid leukemia (AML) patients achieve complete remission (CR), a relapse still occurs in 35-80% and long-term survival rates remain extremely low after relapse (10-20%). At relapse, the common admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::dff56c3c98a465726d87197ae87b8f63
https://dumas.ccsd.cnrs.fr/dumas-03142470
https://dumas.ccsd.cnrs.fr/dumas-03142470
Autor:
Loiseau, Clémence
Publikováno v:
Médecine humaine et pathologie. 2018
Tyrosine kinase inhibitors (TKIs) induce deep lasting molecular responses in patients with chronic myeloid leukemia (CML). However, 60% of patients eligible to TKIs discontinuation will experience loss of major molecular response (MMR). We evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::5aa233261468803b6f5e84eb466231b9
https://dumas.ccsd.cnrs.fr/dumas-02293085
https://dumas.ccsd.cnrs.fr/dumas-02293085
Autor:
Irina P. Suarez, Paula Burdisso, Jérôme Boisbouvier, Rodolfo M. Rasia, Matthieu P. M. H. Benoit
Publikováno v:
Nucleic Acids Research
RepHipUNR (UNR)
Universidad Nacional de Rosario
instacron:UNR
Nucleic Acids Research, Oxford University Press, 2015, 43 (13), pp.6607-6619. ⟨10.1093/nar/gkv627⟩
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Nucleic Acids Research, 2015, 43 (13), pp.6607-6619. ⟨10.1093/nar/gkv627⟩
RepHipUNR (UNR)
Universidad Nacional de Rosario
instacron:UNR
Nucleic Acids Research, Oxford University Press, 2015, 43 (13), pp.6607-6619. ⟨10.1093/nar/gkv627⟩
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Nucleic Acids Research, 2015, 43 (13), pp.6607-6619. ⟨10.1093/nar/gkv627⟩
DCL1 is the ribonuclease that carries out miRNA biogenesis in plants. The enzyme has two tandem double stranded RNA binding domains (dsRBDs) in its C-terminus. Here we show that the first of these domains binds precursor RNA fragments when isolated a
Autor:
Colette Raffoux, Mohamad Mohty, R. Tabrizi, J.Y. Cahn, Ibrahim Yakoub-Agha, J. H. Bourhis, Yosr Hicheri, Norbert Ifrah, Mauricette Michallet, Agnès Buzyn, Nathalie Dhedin, Myriam Labopin, Marie-Lorraine Balere, Didier Blaise, Gérard Socié, Helene Esperou, Noel Milpied
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1867-74. ⟨10.1038/leu.2010.200⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1867-74. 〈10.1038/leu.2010.200〉
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1867-74. ⟨10.1038/leu.2010.200⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1867-74. 〈10.1038/leu.2010.200〉
International audience; This retrospective report assessed the impact of rabbit antithymocyte globulins (ATG), incorporated within a standard myeloablative conditioning regimen prior to allogeneic stem cell transplantation (allo-SCT) using human leuk